Rising incomes, combined with continued low costs for medicines, will drive significant increases in affordability of basic medicines. Pharmerging countries are expected to nearly double their pharmaceutical spending, adding $150-165Bn by 2016. Generic and other products will account for approximately 83% of the increase.